0001104659-23-006235.txt : 20230124
0001104659-23-006235.hdr.sgml : 20230124
20230124170051
ACCESSION NUMBER: 0001104659-23-006235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230120
FILED AS OF DATE: 20230124
DATE AS OF CHANGE: 20230124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Palczuk Linda
CENTRAL INDEX KEY: 0001717580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 23548838
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
tm234325-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-20
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001717580
Palczuk Linda
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
1
0
0
0
Stock Option (Right to Buy)
2.03
2023-01-20
5
G
0
E
60000
0
D
2029-08-07
ADSs
60000
0
D
Stock Option (Right to Buy)
2.03
2029-08-07
ADSs
60000
60000
I
By Trust
Stock Option (Right to Buy)
8.48
2023-01-20
5
G
0
E
42000
0
D
2030-08-07
ADSs
42000
0
D
Stock Option (Right to Buy)
8.48
2030-08-07
ADSs
42000
42000
I
By Trust
Stock Option (Right to Buy)
8.07
2023-01-20
5
G
0
E
42000
0
D
2031-08-03
ADSs
42000
0
D
Stock Option (Right to Buy)
8.07
2031-08-03
ADSs
42000
42000
I
By Trust
Stock Option (Right to Buy)
4.79
2023-01-20
5
G
0
E
42000
0
D
2032-08-03
ADSs
42000
0
D
Stock Option (Right to Buy)
4.79
2032-08-03
ADSs
42000
42000
I
By Trust
These options are fully vested and exercisable as of the date hereof.
The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
On January 20, 2023, the Reporting Person transferred an aggregate of 186,000 options to a revocable trust of which the Reporting Person is trustee.
These options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date, subject to the Reporting Person's continued service at each such vesting date.
These options shall vest in full on the earlier to occur of (a) August 3, 2023 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time.
/s/ Jerad G. Seurer, as attorney-in-fact
2023-01-24